GIK

DRUG3 trials

Sponsors

Tufts Medical Center, Wake Forest University Health Sciences, Xijing Hospital

Conditions

Angina, UnstableCardiac SurgeryCardiopulmonary BypassCardiovascular DiseasesCoronary DiseaseHeart DiseasesHeart Failure, CongestiveMyocardial Infarction

Phase 1

Rapid Administration of Insulin in Sepsis

CompletedNCT00823108

Wake Forest University Health SciencesSeptic Shock

Start: 2009-03-31End: 2010-10-31Target: 20Updated: 2022-04-25

Phase 2

Benefits of GIK in Cardiac Surgery Patients

Xijing HospitalCardiac Surgery, Cardiopulmonary Bypass

Start: 2012-02-29End: 2022-02-28Updated: 2014-10-31

Phase 3

IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.

CompletedNCT00091507

Tufts Medical CenterAngina, Unstable, Cardiovascular Diseases, Coronary Disease +3

Start: 2006-11-30End: 2012-08-31Updated: 2016-03-02

Related Papers

Modified Glucose-Insulin-Potassium Regimen Provides Cardioprotection With Improved Tissue Perfusion in Patients Undergoing Cardiopulmonary Bypass Surgery.

2020-03-1016 citations

Abstract 12942: Modified Glucose-Insulin-Potassium Regimen Provides Cardiac and Renal Protection With Improved Tissue Perfusion and Metabolism in Patients Undergoing Cardiopulmonary Bypass Surgery

Circulation2015-11-10

Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.

2012-03-27159 citations